Professor Terry McCormack and Dr Devin Gray recap some of the new evidence presented at the European Society of Cardiology (ESC) 2023 congress with the greatest impact on primary care: a head-to-head comparison of statins, bempedoic acid for reducing LDL cholesterol, and managing the ongoing cardiovascular risks in patients living with, or who have recovered from, cancer.